- /
- Supported exchanges /
- SHG /
- 688617.SHG
APT Medical Inc (688617 SHG) stock market data APIs
APT Medical Inc Financial Data Overview
APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guidewires, hemostatsis introducers, radial compression devices, aspiration catheters, inflation devices, Y connectors, snare kits, hemostasis valves, L guiding sheaths, balloon occlusion microcatheters, embolic protection device, transjugular liver access sets, and steerable guiding sheaths. It also provides OEM/ODM services, including project design and development, customization, and volume OEM, etc. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get APT Medical Inc data using free add-ons & libraries
Get APT Medical Inc Fundamental Data
APT Medical Inc Fundamental data includes:
- Net Revenue: 1 961 M
- EBITDA: 749 M
- Earnings Per Share: 6
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-04-27
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
APT Medical Inc News
Qiming's Portfolio Company InventisBio Lists on STAR Market
SHANGHAI, July 25, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science and Technol...
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
SHANGHAI, July 11, 2022 /PRNewswire/ -- Qiming Venture Partners announced today the closing of its latest funds totaling US$3.2 billion, including USD Fund VIII at US$2.5 billion and the first closing...
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List
SHANGHAI, April 12, 2022 /PRNewswire/ – Forbes released the 2022 Midas List on April 12, a ranking of the world's top 100 venture capitalists. Nisa Leung, Managing Partner of Qiming Venture Partners...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- 100 000+ API requests per day
- EOD Data - All World Extended
- Splits and Dividends
- Fundamental Data
- Bonds Data
- Options Data
- 1000+ currency pairs
- 1000+ cryptocurrency pairs